JS

Jayne Shaw

BCAL Diagnostics Limited | Executive Chairman, Executive Director
Ms Shaw, on arrival in Australia became Director of Nursing and Chief Executive Officer of two private hospitals. Founding an international healthcare consulting business, which was later acquired by Healthsouth, she co-founded Vision Group, which became an ASX-listed Ophthalmic Doctor equity model. She has founded and lead healthcare companies which have either been sold or listed on the ASX and has worked on international mergers and acquisitions with private equity companies in the UK, Australia and the USA. Currently she co-owns Sydney Breast Clinic and holds existing board positions at Magentus, Ellerston JAADEAustralian PrivateAssets Fund, Mabie Technologies, PharmX and Prospection. Jayne also serves as a Non-Executive Director at Pinnacle Charitable Foundation. Other current listed directorships: BCAL Diagnostics Limited. Former listed directorships (last 3 years): The Citadel Group (Jayne is still a director, but the company is no longer listed). She is chair of the Risk Committee.

Companies and Roles

Company
Title
Tenure
Since
BDX
BCAL Diagnostics Limited
  • Executive Chairman
  • Executive Director
14yrs, 7mthFeb 2010
COO
Corum Group Limited
  • Non-Executive Director
3yrs, 11mthOct 2020
PHX
PharmX Technologies Limited
  • Non-Executive Director
3yrs, 11mthOct 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BDX
BCAL Diagnostics Limited
13/09/242,022,63830,016,7800N/A
PHX
PharmX Technologies Limited
27/08/24N/A2,780,953N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BDX
BCAL Diagnostics Limited
13/09/24
Buy
125,000$0.115$14,375On-market trade
BDX
BCAL Diagnostics Limited
25/07/24
Transfer
1,692,638$0.115$194,653Off-market transfer
BDX
BCAL Diagnostics Limited
25/07/24
Issued
330,000$0.100$33,000As advised by the company
BDX
BCAL Diagnostics Limited
25/07/24
Transfer
1,692,638$0.115$194,653Off-market transfer
BDX
BCAL Diagnostics Limited
14/06/24
Buy
725,000$0.106$76,999On-market trade